EPR - the future of bio/pharmaceutical analysis online summit 2025 logo

The Future of

Bio/Pharmaceutical Analysis

Speakers

Head-Toxicology, Safety Assessment
Syngene International Limited
Head of Microbiology, New Modalities and Parenteral Development
AstraZeneca
Director – Digital Product Development and Marketing
U.S. Pharmacopeia
Vice President of R&D
United States Pharmacopoeia
Head of QA GxP Compliance
Kedrion Biopharma, Inc.
Dow University of Health Sciences
Head of infusion solutions department
Profarma sha
Technical Specialist, LAL Division
Fujifilm Wako Chemicals USA
Director of Global Technical Services
Associates of Cape Cod, Inc.
Senior Director
USP
Product Manager
Veolia
Professor
St. Peter’s Institute Of Pharmaceutical Sciences
Analytical Specialist – External and Member of Nitrosamine Task Force
Novartis
Principal Scientist at Thermo Fisher Scientific
Patheon
Senior Principal Scientific Advisor, Microbial Solutions
Charles River
Associate Director (BPSD, Process Development)
FUJIFILM Diosynth Biotechnologies
Scientific Director
Symphogen
Deputy General Manager (Analytical)
Innoxel Lifesciences Pvt Ltd